Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

International, Multicenter, Investigator-driven Randomized Clinical Trial to Assess the Single vs. Dual Antiplatelet Therapy in Elderly or HBR Patients Undergoing Percutaneous Intervention With Drug-coated Balloons (PICCOLETO IV-EPIC 38)

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT06535568
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:28:35.319767+00:00
Published At
2026-01-22T00:00:00+00:00
Record Updated At
2026-01-22
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Coronary Disease", "Heart Diseases", "Cardiovascular Diseases", "Myocardial Ischemia", "Atherosclerosis", "Arterial Occlusive Diseases", "Vascular Diseases", "Coronary Artery Disease", "Acute Coronary Syndrome", "Coronary Stenosis", "Molecular Mechanisms of Pharmacological Action", "Enzyme Inhibitors", "MTOR Inhibitors", "Protein Kinase Inhibitors", "Physiological Effects of Drugs", "Immunosuppressive Agents", "Antineoplastic Agents", "High Bleeding Risk", "Single Antiplatelet Therapy", "Dual Antiplatelet Therapy", "Cyclooxygenase Inhibitors", "P2Y12 Inhibitor", "Platelet Aggregation Inhibitors", "Aspirin", "Clopidogrel"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2026-01-22"
protocolSection.identificationModule.nctId
"NCT06535568"
protocolSection.identificationModule.officialTitle
"International, Multicenter, Investigator-driven Randomized Clinical Trial to Assess the Single vs. Dual Antiplatelet Therapy in Elderly or HBR Patients Undergoing Percutaneous Intervention With Drug-coated Balloons (PICCOLETO IV-EPIC 38)"
protocolSection.statusModule.overallStatus
"RECRUITING"
protocolSection.designModule.phases
["NA"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Coronary Disease (protocolSection.conditionsModule.conditions)
  • Heart Diseases (protocolSection.conditionsModule.conditions)
  • Cardiovascular Diseases (protocolSection.conditionsModule.conditions)
  • Myocardial Ischemia (protocolSection.conditionsModule.conditions)
  • Atherosclerosis (protocolSection.conditionsModule.conditions)
  • Arterial Occlusive Diseases (protocolSection.conditionsModule.conditions)
  • Vascular Diseases (protocolSection.conditionsModule.conditions)
  • Coronary Artery Disease (protocolSection.conditionsModule.conditions)
  • Acute Coronary Syndrome (protocolSection.conditionsModule.conditions)
  • Coronary Stenosis (protocolSection.conditionsModule.conditions)
  • Molecular Mechanisms of Pharmacological Action (protocolSection.conditionsModule.conditions)
  • Enzyme Inhibitors (protocolSection.conditionsModule.conditions)
  • MTOR Inhibitors (protocolSection.conditionsModule.conditions)
  • Protein Kinase Inhibitors (protocolSection.conditionsModule.conditions)
  • Physiological Effects of Drugs (protocolSection.conditionsModule.conditions)
  • Immunosuppressive Agents (protocolSection.conditionsModule.conditions)
  • Antineoplastic Agents (protocolSection.conditionsModule.conditions)
  • High Bleeding Risk (protocolSection.conditionsModule.conditions)
  • Single Antiplatelet Therapy (protocolSection.conditionsModule.conditions)
  • Dual Antiplatelet Therapy (protocolSection.conditionsModule.conditions)
  • Cyclooxygenase Inhibitors (protocolSection.conditionsModule.conditions)
  • P2Y12 Inhibitor (protocolSection.conditionsModule.conditions)
  • Platelet Aggregation Inhibitors (protocolSection.conditionsModule.conditions)
  • Aspirin (protocolSection.conditionsModule.conditions)
  • Clopidogrel (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.